Pharmanutra S.p.A. (BIT:PHN)
Italy
· Delayed Price · Currency is EUR 79.10
+0.40 (0.51%)
Apr 28, 2026, 5:35 PM CET
Pharmanutra Revenue
In the year 2025, Pharmanutra had annual revenue of 132.16M EUR with 13.78% growth. Pharmanutra had revenue of 37.20M in the quarter ending December 31, 2025, with 15.55% growth.
Revenue
132.16M
Revenue Growth
+13.78%
P/S Ratio
5.73
Revenue / Employee
1.03M
Employees
128
Market Cap
757.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.16M | 16.01M | 13.78% |
| Dec 31, 2024 | 116.15M | 15.44M | 15.33% |
| Dec 31, 2023 | 100.71M | 17.64M | 21.24% |
| Dec 31, 2022 | 83.06M | 14.92M | 21.89% |
| Dec 31, 2021 | 68.14M | 11.38M | 20.04% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| DiaSorin | 1.20B |
| Amplifon | 2.40B |
| EL.En. | 590.85M |
| Philogen | 319.73M |
| Safilo Group | 983.38M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 485.12M |